title: Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin.
authors.affiliation: Institute of Haematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy. pierluigi.zinzani@unibo.it.
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Zinzani
authors.forename: Enrico
authors.initials: E
authors.lastname: Derenzini
authors.forename: Cinzia
authors.initials: C
authors.lastname: Pellegrini
authors.forename: Monica
authors.initials: M
authors.lastname: Celli
authors.forename: Alessandro
authors.initials: A
authors.lastname: Broccoli
authors.forename: Lisa
authors.initials: L
authors.lastname: Argnani
mesh_terms: D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride; D001761:Bleomycin / Q000008:administration & dosage; D000079963:Brentuximab Vedotin; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D018796:Immunoconjugates / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D049268:Positron-Emission Tomography; D018714:Radiotherapy, Adjuvant; D012008:Recurrence; D016879:Salvage Therapy; D014747:Vinblastine / Q000008:administration & dosage; D055815:Young Adult
chemical_list: D018906:Antineoplastic Agents, Alkylating; D018796:Immunoconjugates; D009588:Nitrogen Mustard Compounds; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D000079963:Brentuximab Vedotin; D004317:Doxorubicin; D000069461:Bendamustine Hydrochloride
keywords: Hodgkin lymphoma; bendamustine; brentuximab vedotin; refractory; relapsed